Please login to the form below

Not currently logged in
Email:
Password:

government

This page shows the latest government news and features for those working in and with pharma, biotech and healthcare.

Roche’s Tamiflu successor hits the mark in complicated flu

Roche’s Tamiflu successor hits the mark in complicated flu

Roche introduced its mainstay flu drug Tamiflu (oseltamivir) almost 20 years ago, and it has been a big earner for the company – in part fuelled by government stockpiling in case of

Latest news

More from news
Approximately 24 fully matching, plus 1,100 partially matching documents found.

Latest Intelligence

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    As biosimilars surge into the insulin market, governments  are urged to seize ‘the opportunity of the century’. ... Individual case studies may have the most powerful impact, with grass-roots feedback influencing government thinking.

  • Diversity and inclusion in the pharma industry Diversity and inclusion in the pharma industry

    Now at a time when diversity and inclusion (D&I) are finally on the agenda, or at least there is government-driven introspection on the gender pay gap (GPG) and a ... The recent Government Race Disparity Audit was evidence of the impact of inequality for

  • ‘How is your day?’ ‘How is your day?’

    The initiative shares evidence that supports governments’efforts to create practical sourcing polices that will improve access to plasma products.

  • Advancing women in healthcare Advancing women in healthcare

    Centers for Disease Control and Prevention (CDC) and overseeing a restructuring of the government agency’s multibillion dollar budget and 10, 000 employees.

  • 30 Women Leaders in UK Healthcare

    ecosystem. MSD’s expansion over the coming years will help the company hold the government to its promises included in the Life Sciences Sector Deal. ... Negotiations between the industry and the government are now under way for another four-year

More from intelligence
Approximately 4 fully matching, plus 224 partially matching documents found.

Latest appointments

  • Building trust in our industry Building trust in our industry

    Building trust in our industry. For the last 18 years the Edelman Trust Barometer has tracked levels of trust across the world in the four institutions of business, government, media and

  • New appointments at 90TEN and WA Health New appointments at 90TEN and WA Health

    Having started her career as a campaigner in charities including Mencap and Mind, Caroline worked as a political adviser to a government minister and local council leaders.

  • Rubica appoints former GSK executive communications and engagement lead Rubica appoints former GSK executive communications and engagement lead

    Prior to her new role, Gosling spent just under five years at pharma giant GlaxoSmithKline ( GSK) in a range of business leadership roles across communications, employee engagement, multichannel marketing, government affairs

  • Acumen appoints new strategy director Acumen appoints new strategy director

    Bols has also worked in the areas of market access, government affairs, public affairs, health policy and corporate communications to name a few and he has also advised companies engaging with

  • Pfizer’s Alan Maine moves to Edelman Pfizer’s Alan Maine moves to Edelman

    Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... Prior to his time with Pfizer, Maine was

More from appointments
Approximately 2 fully matching, plus 93 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 124 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics